Histidine

Histidine

SCHEMBL3498728

N[C@@H](Cc1cnc[nH]1)C(=O)O.[Fe]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.97
▸ SLC7A5 Q01650 1/20 0.97
▸ CPB2 Q96IY4 1/20 0.57
▸ ALDH1A1 P00352 4/20 0.56
▸ HRH4 Q9H3N8 3/20 0.56
▸ HRH3 Q9Y5N1 3/20 0.56
▸ NFKB1 P19838 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ GLA P06280 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ THPO P40225 1/20 0.56
▸ LMNA P02545 1/20 0.54
▸ APEX1 P27695 1/20 0.54
▸ BLM P54132 1/20 0.54
▸ GABRA1 P14867 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ GABRR1 P24046 1/20 0.53
▸ GABRR2 P28476 1/20 0.53
▸ GABRA5 P31644 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histidine SCHEMBL137600 0.98 CYP3A4 (1.00) CYP3A4SLC7A5CPB2ALDH1A1HRH4
Histidine SCHEMBL388560 0.98 CYP3A4 (1.00) CYP3A4SLC7A5CPB2ALDH1A1HRH4
Histidine SCHEMBL3260 0.98 CYP3A4 (1.00) CYP3A4SLC7A5CPB2ALDH1A1HRH4
Histidine SCHEMBL30852263 0.98 CYP3A4 (1.00) CYP3A4SLC7A5CPB2ALDH1A1HRH4
Histidine SCHEMBL19974306 0.98 CYP3A4 (1.00) CYP3A4SLC7A5CPB2ALDH1A1HRH4
Histidine SCHEMBL28071764 0.98 CYP3A4 (1.00) CYP3A4SLC7A5CPB2ALDH1A1HRH4
D-Histidine SCHEMBL288043 0.98 CYP3A4 (1.00) CYP3A4SLC7A5CPB2ALDH1A1HRH4
Histidine SCHEMBL25362582 0.97 CYP3A4 (0.97) CYP3A4SLC7A5CPB2ALDH1A1HRH4
Histidine SCHEMBL25357958 0.97 CYP3A4 (0.97) CYP3A4SLC7A5CPB2ALDH1A1HRH4
Histidine SCHEMBL25267810 0.97 CYP3A4 (0.97) CYP3A4SLC7A5CPB2ALDH1A1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109965104-A A kind of composition and its preparation method and application containing Sodium Hyaluronate 华熙生物科技股份有限公司 2019-07-05 — — CN claimed
US-20230145406-A1 DIVALENT METAL-CONTAINING BIOMATERIALS AND METHODS OF USE UNIVERSITY OF OREGON (US) 2023-05-11 — — US disclosed
CN-113277954-B Amino acid metal chelate micro-nano powder and preparation method thereof 英德市匠心新材料股份有限公司 2023-04-28 — — CN disclosed
CN-111662342-B Preparation method of tannin-histidine metal complex 太原理工大学 2022-09-23 — — CN disclosed
CN-113277954-A Amino acid metal chelate micro-nano powder and preparation method thereof 英德市匠心新材料股份有限公司 2021-08-20 — — CN disclosed
WO-2021011540-A1 ORAL IRON COMPOSITIONS AND APPLICATION FOR BABY PIGS NOVUS INTERNATIONAL INC. (US) 2021-01-21 — — WO disclosed
CN-106730049-B Biocompatible internal stent material 深圳汉诺医疗科技有限公司 2020-05-12 — — CN disclosed
CN-110204492-A A kind of preparation method of novel amino chelated iron crystal 南京理工大学 2019-09-06 — — CN disclosed
CN-109965104-A A kind of composition and its preparation method and application containing Sodium Hyaluronate 华熙生物科技股份有限公司 2019-07-05 — — CN disclosed
CN-102712911-B Comprise the allelic Brassica plants of sudden change FAD3 BAYER CROPSCIENCE N.V. (BE) 2016-01-13 — — CN disclosed
CN-102712911-A Brassica plants comprising mutant FAD3 alleles BAYER BIOSCIENCE NV 2012-10-03 — — CN disclosed
US-20100172862-A1 STABLE ANTIBODY COMPOSITIONS AND METHODS OF STABILIZING SAME ABBOTT LABORATORIES (US) 2010-07-08 — — US disclosed
US-20080090297-A1 Methods for determining the metal bioavailability of metal sources NOVUS INTERNATIONAL INC. (US) 2008-04-17 — — US disclosed
US-20040137483-A1 Lipoxygenase proteins and nucleic acids BRASH ALAN R (US) 2004-07-15 — — US disclosed
US-6649355-B2 Lipoxygenase proteins and nucleic acids VANDERBILT UNIVERSITY 2003-11-18 — — US disclosed
US-20010046672-A1 Lipoxygenase proteins and nucleic acids NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2001-11-29 — — US disclosed
US-6204037-B1 NUCLEOTIDE SEQUENCES THAT CODE ENZYMATIC POLYPEPTIDE; FOR MONITORING THE METABOLISM OF ARACHIDONIC ACID IN PREFERENTIAL CELLS; AND TREATMENT OF INFLAMMATION AND INJURIES VANDERBILT UNIVERSITY 2001-03-20 — — US disclosed
Send feedback